For a substantial portion of patients experiencing long COVID and new-onset chest pain, ischemia with nonobstructive coronary arteries (INOCA) appears to be the underlying cause of their angina, ...
(UPDATED) Ischemia with no obstructive coronary arteries (INOCA) produces symptoms that affect physical functioning, mental health, and quality of life, a new survey of patients diagnosed with the ...
The October 25, 2022, Yale Cardiovascular Medicine Grand Rounds, “Seeing the Invisible: Ischemia and No Obstructive Coronary Artery Disease,” was presented by Samit Shah, MD, PhD, assistant professor ...
NEW ORLEANS — Coronary function testing performed in patients with symptomatic ischemia but nonobstructive arteries has a high diagnostic yield, is safe, and often leads to treatment that improves ...
BETHESDA, Md., March 30, 2026--(BUSINESS WIRE)--CorVista Health, a leader in noninvasive cardiovascular diagnostics, today announced new data evaluating a physiologic signal–based machine-learning ...
Please provide your email address to receive an email when new articles are posted on . Learning from women’s experiences may be key to improving INOCA diagnosis and care. Four themes that may improve ...
Please provide your email address to receive an email when new articles are posted on . RANCHO PALOS VERDES, Calif. — Observational studies show ischemia with no obstructive CAD is “common” among ...
CHICAGO, November 05, 2025--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-powered Precision Cardiovascular Medicine company, today announced that the Company will be ...
CHICAGO -- The WARRIOR trial was not able to prove that intensive medical therapy reduced major adverse cardiovascular events (MACE) in women with ischemia but no obstructive disease. For symptomatic ...
A new study led by investigators at the Smidt Heart Institute at Cedars-Sinai found symptoms of the increasingly common cardiovascular condition known as ischemia with no obstructive coronary arteries ...
CHICAGO -- Coming this weekend, the American College of Cardiology (ACC) annual conference will feature research exploring new frontiers for GLP-1 drugs in cardiovascular medicine, and foundational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results